Phillip Gold

Executive Director-Clinical Research Center at McGill University Health Center

Phillip Gold

Phillip Gold

Executive Director-Clinical Research Center at McGill University Health Center

Overview
Career Highlights

McGill University Health Cente

RelSci Relationships

591

Number of Boards

9

Birthday

1941

Age

77

Relationships

Founder at BioContact (Québec), Inc.

National Executive Director at Weizmann Canada

Principal & Vice Chancellor at McGill University

Chief Executive Officer & Founder at Ellipsis Neurotherapeutics, Inc.

Former Chief Financial Officer at NATRIX Separations, Inc.

Portfolio Manager at Fonds de Solidarité FTQ

Member, Montreal Scientific Advisory Board at Weizmann Canada

Member, Scientific Advisory Board at Effector Therapeutics, Inc.

Director at Aurelium BioPharma, Inc.

Director at Aurelium BioPharma, Inc.

Subscribe to RelSci Professional to see 591 more Relationships
In The News
Subscribe now to see full news coverage
Paths to Phillip Gold
Potential Connections via
Relationship Science
You
Phillip Gold
Executive Director-Clinical Research Center at McGill University Health Center
Education

McGill University is a public research university located in Montreal, Quebec, Canada. Founded in 1821 during the British colonial era, the university bears the name of James McGill, a prominent Montreal merchant from Glasgow, Scotland and alumnus of Glasgow University, whose bequest formed the beginning of the university.

Memberships
Member
Current

ADVANCEMENT OF SCIENCE AND MEDICINE.

Member
Current

PUBLICATION OF RESEARCH JOURNALS AND DISSEMINATION OF RELATED INFORMATION.

Member
Current
Subscribe now to see memberships for over 7 million people
Career History
Executive Director-Clinical Research Center
1968 - Current

McGill University Health Center provides health care services. The firm offers multidisciplinary patient centric care services. The company was founded in 1997 and is headquartered in Montreal, Canada.

Professor-Physiology & Oncology
Current

McGill University is a public research university located in Montreal, Quebec, Canada. Founded in 1821 during the British colonial era, the university bears the name of James McGill, a prominent Montreal merchant from Glasgow, Scotland and alumnus of Glasgow University, whose bequest formed the beginning of the university.

Professional
1980 - Prior

Montréal General Hospital Corp. provides community services. The firm offers patient care through diagnosis, treatment, research, and teaching. The company was founded in 1821 and is headquartered in Montréal, Canada.

Subscribe now for extended career history
Boards & Committees
Chairman
Current

Aurelium BioPharma Inc., develops therapeutics and diagnostics for the treatment of drug-resistant cancers. The company has developed several diagnostic tests for the detection of breast, ovarian as well as drug-resistant cancers. The firm has a strong drugable pipeline of novel targets and complimentary diagnostic products that are utilized in its strategic collaborations and out-licensing efforts. The company was founded in May 1998 and is headquartered in Laval, Canada.

Director
2007 - Prior

Bradmer Pharmaceuticals, Inc. engages in the development and commercialization of cancer therapies. The company was founded on February 10, 2006 and is headquartered in Toronto, Canada.

Director
2003 - 2005

The fundamental investment objective of BioCapital is to provide investors superior capital appreciation by investing in equity securities of public companies with high growth potential in biotechnology industries. They seek to achieve this fundamental objective by investing in a diversified portfolio of public companies primarily in the following sectors of the biotechnology industry: therapeutics in the fields of cancer, cardiology, infectious diseases, immune system and central nervous system. The firm also invests in companies developing platform technologies in the fields on genomics and proteomics, drug delivery, theranostics, nanotechnology and monoclonal antibody.

Subscribe now to see 4 more corporate board memberships
Member, Montreal Scientific Advisory Board
Current
Board Member
Prior

The Burroughs Wellcome Fund is an independent private foundation dedicated to advancing the biomedical sciences by supporting research and other scientific and educational activities. BWF’s financial support is channeled primarily through competitive peer-reviewed award programs. BWF makes grants primarily to degree-granting institutions on behalf of individual researchers, who must be nominated by their institutions. To complement these competitive award programs, BWF also makes grants to nonprofit organizations conducting activities intended to improve the general environment for science.

Subscribe now to see non-profit board memberships for over 7 million people
Subscribe now to see government board memberships for over 7 million people